EIKN vs SCTX: stock comparison and AI forecast
Eikon Therapeutics, Inc. (EIKN) and Scribe Therapeutics, Inc. (SCTX) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
EIKN Eikon Therapeutics, Inc.
- Market Cap
- $316M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
SCTX Scribe Therapeutics, Inc.
- Market Cap
- $293M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- EIKN and SCTX have similar market capitalizations ($316M and $293M).
- Both companies share the SEC industry classification Biological Products, (No Diagnostic Substances).
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | EIKN | SCTX |
|---|---|---|
| Market Cap | $316M | $293M |
| P/B Ratio | 0.68x | – |
| Book Value/Share | $8.61 | – |
Financial Health
| Metric | EIKN | SCTX |
|---|---|---|
| Current Ratio | 9.89x | 0.57x |
| D/E Ratio | 0.67x | – |
| Financial Leverage | 1.67x | – |
| Interest Coverage | -18.5x | -10.7x |
| Working Capital | $492M | -$34M |
Dividend & Shareholder Information
| Metric | EIKN | SCTX |
|---|---|---|
| Shares Outstanding | 54M | 19M |
EIKN vs SCTX: stock comparison and AI forecast
Which is bigger, EIKN or SCTX?
EIKN and SCTX have similar market capitalizations ($316M and $293M).
Which one does Intratio's AI model rank higher, EIKN or SCTX?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.